To Amanda Wagner, the past two years or so she’s spent at Immunitas feels like a microcosm of her entire career up to now. Trained in neuroscience and equipped with an MBA, Wagner’s 16-year biopharma…
In the early days of the pandemic, there was a mad scramble for information. What was a coronavirus, how likely was a vaccine and how soon could it be developed? At Johnson & Johnson, where Janssen…
Bristol Myers Squibb is looking to shine a light on the rarely diagnosed heart condition hypertrophic cardiomyopathy (HCM) as it awaits an FDA decision on a proposed drug to treat it. The unbranded…
The Institute for Clinical and Economic Review on Tuesday morning released its latest on
Accelus was formed earlier this year after a merger between Integrity Implants and Fusion Robotics, both of which have spent years developing technology to improve minimally invasive spinal surgeries.
Medtronic secured an FDA clearance for the newest generation of its ingestible digital camera. It will serve as the basis for at-home remote diagnostics programs, which are in high-demand since the…
A year after launching with ex-Horizon Chief Scientific Officer Shao-Lee Lin at the helm, Acelyrin has picked up a whopping $250 million series B to bankroll an asset licensed from Affibody. The…
Al Sandrock is retiring as head of R&D at Biogen. After 23 years at the company, the scientist will clear his desk by the end of the year, leaving behind a legacy of big R&D successes that are…
With colonoscopy rates plummeting amid the COVID-19 pandemic, it’s time for a new early screening method for colorectal cancer that’s less invasive and more easily accessible, while also being just as…
More than a year later, the Department of Health and Human Services has rolled back a Trump-era policy that had limited the FDA’s oversight of lab-developed tests, or LDTs, which include a wide range…
